Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Relief agencies
@ProjectHopeOrg,@DirectRelief and Red Cross are providing support in China related to the#Coronavirus. Lilly and the Lilly Foundation donated ~$400,000 toward these efforts to help send much-needed supplies to hospitals and health centers in Wuhan.#WeAreLillypic.twitter.com/4eyBCsx8HT
-
According to surveys of people with migraine, patients prioritize fast and complete elimination of pain. At Lilly, we strive to meet the needs of patients. Learn more about our commitment here: https://e.lilly/2Ocghlu
#PainEliminationpic.twitter.com/J23BK0sGE9
-
We are excited to provide patients and doctors with a new acute treatment for adults with
#migraine that offers the potential for total pain elimination during an attack. https://e.lilly/36GdpDD#PainEliminationpic.twitter.com/gODPUSsGPF
-
ICYMI: Lilly announced the
@US_FDA has granted priority review for the New Drug Application for patients living with RET fusion-positive non-small cell#lungcancer, RET-mutant medullary#thyroidcancer and RET fusion-positive#thyroidcancer. Learn more: https://e.lilly/36vQsTK pic.twitter.com/PBTpmk3KdV
-
Today we're sharing our Q4 and full-year 2019 results, including pipeline progress. Here's the full story: https://e.lilly/2GCYCit
$LLYpic.twitter.com/lCcH9wLWju
-
Our new, state-of-the-art manufacturing facility in North Carolina will allow us to stay ahead of patient need for existing Lilly products as well as life-changing medicines expected to launch in the coming years.
#WeAreLillypic.twitter.com/G8KzDV2hzO -
In a groundbreaking new collaboration, we’re partnering with industry peers and
@GatesFoundation to support@LastMileHealth and@Living_Goods, delivering community-based health care to 1.7 million people in up to six African countries. Learn more: https://e.lilly/38dq8iA pic.twitter.com/JZkerBjq71
-
Just announced: Lilly will acquire
@DermiraInc, a biopharma company dedicated to developing new therapies for chronic skin conditions. This agreement will support our efforts to make life better for people living with immunological conditions: https://e.lilly/37QMvdl#immunologypic.twitter.com/xMGfBj2bRV
-
Just announced: our new robotic laboratory, designed to accelerate the drug discovery process. The Lilly Life Sciences Studio lab expands our research footprint in San Diego, featuring collaborator
@StrateosLab's cloud-based capabilities. https://e.lilly/37NGj5R#WeAreLillypic.twitter.com/6GlZjnQa05 -
Regardless of your circumstances, please call the Lilly Diabetes Solution Center at (833) 808-1234 if you cannot afford your Lilly insulin. We have solutions that can make life easier for you. Please call us. We want to help. Learn more at https://www.lilly.com .pic.twitter.com/aQ4joZFw2U
-
Today we’re announcing our 2020 financial guidance. Tune in to
@CNBC at 6 p.m. ET as CEO Dave Ricks speaks with@JimCramer on this news and more, and read the full story here: https://e.lilly/2Pu84Kf$LLYpic.twitter.com/gTUOFDoR43
-
We are excited to announce that the EU CHMP recommended the use of one of our treatments for EGFR-mutated non-small cell
#lungcancer. Learn more: https://e.lilly/2ErfWWV#NSCLCpic.twitter.com/v4oX9vbqx4
-
We are excited to see so many patient advocates at
#SABCS19 who are here to learn more about the latest research advances in metastatic breast cancer. You inspire our research efforts and our commitment to do#MoreforMBC.pic.twitter.com/xm9gkL0VAp -
Stomach cancer is the 5th most common cancer in the world, and the 3rd leading cause of cancer death worldwide. https://e.lilly/37zXoAV pic.twitter.com/BHaB3dlVT1
Prikaži ovu nit -
Just announced: Lilly unveils its first shared innovation space, located in South San Francisco. Lilly Gateway Labs is designed to speed the discovery of innovative medicines through collaboration with the Bay Area’s biotech community. https://e.lilly/2RaXcSU
#WeAreLilly#biotechpic.twitter.com/Nt7ktofVHm
-
We look forward to improving
#IBD care with@KlickHealth &@BostonChildrens whose novel solution@health_voyager was chosen as the winner of our first digital health open innovation challenge. https://e.lilly/2DB8bwX#WeAreLillypic.twitter.com/RaXiVpSesA
-
Most types of
#lungcancer do not cause any symptoms until it spreads, so the earlier it is caught, the better the chance of survival. Learn about the symptoms and importance of screening: https://e.lilly/33kzNkv#LCAMpic.twitter.com/AGK0CsBgDM
-
Did you know
#lungcancer is the leading cause of cancer deaths worldwide – estimated to be responsible for almost one in five? Learn more about the symptoms: https://e.lilly/33kzNkv#LCAMpic.twitter.com/PwxGTUL9tl
-
Alzheimer’s disease is one of the biggest unmet medical needs of our time, and Lilly remains determined to find solutions. This
#AlzheimersAwarenessMonth, we’re shining a light on clinical trial participation and research on our R&D podcast: http://e.lilly/2V85kH1#WeAreLillypic.twitter.com/5aDyia6b79
-
To commence Lilly's first digital health open innovation challenge, held at our headquarters, five finalists present their solutions aimed at transforming
#IBD care. Stay tuned for an update on our winning solution!#WeAreLillypic.twitter.com/fBv6u0kKbf
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.